Demers-Mathieu Veronique, Nielsen Søren Drud, Underwood Mark A, Borghese Robyn, Dallas David C
Nutrition Program, School of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR.
Department of Pediatrics, University of California, Davis, Sacramento, CA.
J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):318-324. doi: 10.1097/MPG.0000000000001719.
Our previous studies suggested that human milk proteases begin to hydrolyze proteins in the mammary gland and continue within the term infant' stomach. No research has measured milk protease and pepsin activity in the gastric aspirates of preterm infants after human milk feeding. This study investigated how the concentrations of human milk proteases and protease inhibitors changed in the premature infant stomach.
Human milk and infant gastric samples were collected from 18 preterm-delivering mother-infant pairs (24-32 week gestational age). Paired human milk and gastric samples were collected across postnatal age (2-47 days). Protease concentrations were determined by spectrophotometric or fluorometric assays, and the concentrations of protease inhibitors and bioactive proteins were determined by enzyme-linked immunosorbent assay. Paired t tests were applied to compare enzymes, antiproteases, and bioactive proteins between human milk and gastric samples.
Our study reveals that although human milk proteases, including carboxypeptidase B2, kallikrein, plasmin, cathepsin D, elastase, thrombin, and cytosol aminopeptidase, are present in the preterm infant stomach, only plasmin and cathepsin D can actively hydrolyze proteins at gastric pH. Enzyme-linked immunosorbent assay and peptidomic evidence suggest that all milk antiproteases as well as lactoferrin and immunoglobulin A are partially digested in the preterm stomach.
Most human milk proteases are active in milk but not at preterm infant gastric pH. Only cathepsin D and plasmin have potential to continue degrading milk proteins within the preterm infant stomach.
我们之前的研究表明,人乳蛋白酶在乳腺中开始水解蛋白质,并在足月儿胃内持续发挥作用。尚无研究测量过早产儿喂食人乳后胃吸出物中的乳蛋白酶和胃蛋白酶活性。本研究调查了人乳蛋白酶和蛋白酶抑制剂在早产儿胃内的浓度变化情况。
从18对早产母婴(孕龄24 - 32周)中收集人乳和婴儿胃样本。在出生后不同时期(2 - 47天)收集配对的人乳和胃样本。通过分光光度法或荧光法测定蛋白酶浓度,通过酶联免疫吸附测定法测定蛋白酶抑制剂和生物活性蛋白的浓度。应用配对t检验比较人乳和胃样本中的酶、抗蛋白酶和生物活性蛋白。
我们的研究表明,尽管早产儿胃内存在人乳蛋白酶,包括羧肽酶B2、激肽释放酶、纤溶酶、组织蛋白酶D、弹性蛋白酶、凝血酶和胞质氨基肽酶,但只有纤溶酶和组织蛋白酶D能在胃内pH值条件下积极水解蛋白质。酶联免疫吸附测定法和肽组学证据表明,所有乳抗蛋白酶以及乳铁蛋白和免疫球蛋白A在早产儿胃内均被部分消化。
大多数人乳蛋白酶在乳汁中具有活性,但在早产儿胃内pH值条件下无活性。只有组织蛋白酶D和纤溶酶有潜力在早产儿胃内继续降解乳蛋白。